Exact Mass: 410.1988
Exact Mass Matches: 410.1988
Found 500 metabolites which its exact mass value is equals to given mass value 410.1988
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diflorasone
Diflorasone is only found in individuals that have used or taken this drug. It is a topical corticosteroid used to treat itching and inflammation of the skin.The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
Benfuracarb
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
Quinaprilat
Quinaprilat is the active metabolite of quinapril. Quinapril is a prodrug and is a long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor used in the treatment of arterial hypertension or chronic heart failure (PMID: 19761414). Prodrugs are compounds that must be metabolized in the gut or liver before they can become active. Quinaprilat functions through blocking the conversion of angiotensin I to the vasoconstrictor angiotensin II, thereby inhibiting bradykinin degradation which reduces vascular oxidative stress and endothelial activity (PMID: 15223904). It is eliminated mainly in urine. It has no teratogenic, mutagenic or carcinogenic effect. Quinaprilat is only found in individuals who have taken or consumed the drug quinapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
risperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics CONFIDENCE standard compound; INTERNAL_ID 1505 CONFIDENCE standard compound; INTERNAL_ID 8513 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3353 Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
Risperidone
Risperidone is an atypical antipsychotic medication approved in 1993. It is most often used to treat delusional psychosis (including schizophrenia), but risperidone (like other atypical antipsychotics) is also used to treat some forms of bipolar disorder, psychotic depression and Tourette syndrome. Generally lower doses are used for autistic spectrum disorders than are used for schizophrenia and other forms of psychosis; Risperidone is a very strong dopamine blocker (antagonist); Risperidone is a very strong dopamine blocker (antagonist); i.e., it inhibits functioning of postsynaptic dopamine receptors. An anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to diazepam; i.e., it inhibits functioning of postsynaptic dopamine receptors. Risperidone (Belivon, Rispen, Risperdal; in the United States) is an atypical antipsychotic medication. It was approved by the United States Food and Drug Administration (FDA) in 1993. It is most often used to treat delusional psychosis (including schizophrenia), but risperidone (like other atypical antipsychotics) is also used to treat some forms of bipolar disorder, psychotic depression and Tourette syndrome; risperidone has received approval from the Food and Drug Administration (FDA) for symptomatic treatment of irritability in autistic children and adolescents. Risperidone is now the most commonly prescribed antipsychotic medication in the United States. Risperidone is an atypical antipsychotic medication approved in 1993. It is most often used to treat delusional psychosis (including schizophrenia), but risperidone (like other atypical antipsychotics) is also used to treat some forms of bipolar disorder, psychotic depression and Tourette syndrome. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
Pteroside D
Constituent of Pteridium aquilinum (bracken fern). Pteroside D is found in green vegetables and root vegetables. Pteroside D is found in green vegetables. Pteroside D is a constituent of Pteridium aquilinum (bracken fern).
Pteroside A
Pteroside A is found in green vegetables. Pteroside A is a constituent of Pteris aquilinum (bracken fern)
Heliocide H4
Heliocide H4 is found in cottonseed. Heliocide H4 is a constituent of Gossypium hirsutum (cotton). Constituent of Gossypium hirsutum (cotton). Heliocide H4 is found in cottonseed.
Scorzoside
Constituent of Scorzonera hispanica (scorzonera). Scorzoside is found in coffee and coffee products and root vegetables. Scorzoside is found in coffee and coffee products. Scorzoside is a constituent of Scorzonera hispanica (scorzonera).
Heliocide H3
Heliocide H3 is found in fats and oils. Heliocide H3 is a constituent of Gossypium hirsutum (cotton)
Heliocide H2
Heliocide H2 is found in fats and oils. Heliocide H2 is a constituent of Gossypium hirsutum (cotton). Constituent of Gossypium hirsutum (cotton). Heliocide H2 is found in fats and oils.
Heliocide H1
Constituent of Gossypium hirsutum (cotton). Heliocide H1 is found in cottonseed and fats and oils. Heliocide H1 is found in cottonseed. Heliocide H1 is a constituent of Gossypium hirsutum (cotton).
(R)-Kanzonol Y
(R)-Kanzonol Y is found in herbs and spices. (R)-Kanzonol Y is a constituent of Glycyrrhiza glabra (licorice)
2-Geranyl-2',3,4,4'-tetrahydroxydihydrochalcone
2-Geranyl-2,3,4,4-tetrahydroxydihydrochalcone is found in fruits. 2-Geranyl-2,3,4,4-tetrahydroxydihydrochalcone is a constituent of Artocarpus communis (breadfruit) Constituent of Artocarpus communis (breadfruit). 2-Geranyl-2,3,4,4-tetrahydroxydihydrochalcone is found in fruits.
1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4,6-trihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one
Tafluprost free acid
Tafluprost free acid is only found in individuals that have used or taken Tafluprost. Tafluprost free acid is a metabolite of Tafluprost. Tafluprost free acid belongs to the family of Halogenated Fatty Acids. These are fatty acids contaning an halogen atom (Cl,F,I,Br).
Brucine N-oxide
Famitinib
Flumethasone
Rhinacanthin C
Tafluprost acid
19-Monoacetyl cincassiol A
19-monoacetyl cincassiol a is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 19-monoacetyl cincassiol a can be found in chinese cinnamon, which makes 19-monoacetyl cincassiol a a potential biomarker for the consumption of this food product.
Rhinacanthin C
A naphthoquinone isolated from Rhinacanthus nasutus and has been shown to exhibit antiviral activity.
5-[9-[5-(furan-3-ylmethyl)furan-3-yl]-2,6-dimethylnon-5-enylidene]-4-hydroxy-3-methylfuran-2-one
4-Hydroxy-5-methyl-3-[8-oxo-9-hydroxyfarnesyl]-coumarin
5-[9-[5-(furan-3-ylmethyl)furan-3-yl]-2,6-dimethylnon-6-enylidene]-4-hydroxy-3-methylfuran-2-one
Pseudobrucine
A monoterpenoid indole alkaloid that is brucine in which the hydrogen at position 16 has been replaced by a hydroxy group.
3,4,6-Trihydroxy-2-oxo-3,5-diprenyldihydrochalcone
PIPERACETAZINE
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
(5a)|21,22alpha-epoxy-2-methoxy-19-methyl-(21alpha)-21,22-dihydro-16,19-seco-strychnidine-10,16-dione
11alpha,13-dihydrodehydrocostuslactone-8-O-beta-D-glucoside|11beta,13-Dihydro,8-O-beta-D-glucopyranoside-(1alpha,5alpha,6alpha,8alpha)-8-Hydroxy-4(15),11(13),10(14)-guaiatrien-12,6-olide|11betaH-11,13-dihydrodehydrocostuslactone 8-O-beta-D-glucoside
2alpha-(beta-D-glucopyranosyloxy)-5alphaH-eudesma-4(15),11(13)-dien-12,8beta-olide
4-O-acetyl-6beta,9beta-dihydroxypulchellin-2-O-isobutyrate
(12S)-15,16-epoxy-3beta,4alpha,6beta,12-tetrahydroxy-18-methoxyneocleroda-13(16),14-dien-20,19-olide
(1S,5S,6R,7S,10R)-1-hydroxy-4-methoxy-5-methylbutanoyloxy-2,9-dioxoxanth-11-en-6,12-olide
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-4-methoxy-19-methyl-, (21.alpha.,22.alpha.)-
8beta-angeloyloxy-3beta,10beta-epoxy-1beta,15-dihydroxy-3alpha-methoxy-4beta-H-germacran-11(13)-en-6alpha,12-olide|helivypolide I
N1-methoxycarbonyl-12-hydroxy-Delta16,17-kopsinine
12-hydroxy-2,16-dimethoxy-strychnidin-10-one|Rindlin
(1R*,2R*,3S*,5S*,6S*,7S*,10S*)-2,3,14-triacetoxy-1,10-epoxybicyclogermacr-4(15)-en-5-ol
cis-4-((E)-3,4-dimethoxystyryl)-3-(2,4,5-trimethoxyphenyl)cyclohex-1-ene|cis-4-<(E)-3,4-dimethoxystyryl>-3-(2,4,5-trimethoxyphenyl)cyclohex-1-ene
1,3,5-Tri-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetriol
2,3-dihydro-7-methoxy-2R*,3R*-dimethyl-2[4,8-dimethyl-3(E),7-nonadienyl-6-one]-furo[2,3-b]chromone|kopetdaghin E
2,3-dihydro-7-methoxy-2S*,3R*-dimethyl-2-[4,8-dimethyl-3(E),7-nonadien-6-onyl]-furo[3,2-c]coumarin
1,3,6-Tri-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetriol
4,14,15-triacetoxypseudoguaian-12,6-olide|rudbeckolide
dunnianoside I|p-[(1S,4R)-1,2,2-trimethyl-4-O-beta-D-glucopyranosylcyclopentyl]benzoic acid
4S,5R-12-O-beta-D-glucopyranosyl-eremophil-7(11)(Z),9-dien-8-one-12-oic acid
alatoside G|beta-D-glucopyranosyloxyl 9-oxo-4,11(13)-eudesmadien-12-oate
11-Methoxy-Vomicine|4-hydroxy-3-methoxy-19-methyl-16,19-seco-strychnidine-10,16-dione|4-Hydroxy-3-methoxy-N-methyl-sec.-pseudostrychnin
3alpha-hydroxy-1alpha,5alpha,7alpha(H)-guaia-4(15),10(14),11(13)-trien-12-oic acid beta-glucopyranosyl ester
3beta,6beta,8alpha-triacetoxy-4beta,5alpha-epoxy-1-oxogermacr-10(14)-ene
N-p-coumaroyl-N-feruloylputrescine|p-coumaroylferuloylputrescine
bipinnatone B
A member of the class of dihydrochalones that is dihydrochalcone hydroxylated at C-2, C-4, C-6 and C-4 and substituted by a geranyl group at C-3. It is isolated from the aerial parts of Boronia bipinnata and exhibits antimalarial activity.
6beta-hydroxy-acetoxy-9beta-hydroxypullchellin-2-O-isobutirate
(19S)-17,19-epoxy-(20alphaH)-coryn-16-ene-5beta,16-dicarboxylic acid dimethyl ester|19alpha-methyl-(20alpha)-18-oxa-yohimb-16-ene-5beta,16-dicarboxylic acid dimethyl ester
cis-3-(3,4-dimethoxyphenyl)-4-((E)-2,4,5-trimethoxystyryl)cyclohex-1-ene|cis-3-(3,4-dimethoxyphenyl)-4-<(E)-2,4,5-trimethoxystyryl>cyclohex-1-ene|cis-3-(3,4-dimethoxyphenyl)-4-<(E)-2,4,5-trimethoxystyryl>cyclohex-1-
dimethyl (1R,4S,12R,13S,16R)-17-oxo-5,14-diazahexacyclo[12.4.3.0^{1,13.0^{4,12.0^{6,11.0^{12,16]henicosa-6,8,10-triene-4,5-dicarboxylate
9alpha-Hydroxy-8-desacyloxy-8beta-isovaleryloxy-melnerin A
3beta-angeloyloxy-8beta,10beta-dihydroxy-6beta-methoxyeremophilenolide
1alpha-methoxy-3alpha,15-dihydroxy-3,10-epoxy-8beta-O-methylbutanoyl-4,11(13)-germacradien, 6alpha,12-olide
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 3,4-dihydroxy-2-methylidenebutanoate
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 3,4-dihydroxy-2-methylidenebutanoate
Flumethasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XB - Corticosteroids, moderately potent, other combinations D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AB - Corticosteroids, moderately potent (group ii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2823 INTERNAL_ID 2823; CONFIDENCE standard compound
Ala His Pro Ser
Ala His Ser Pro
Ala Pro His Ser
Ala Pro Ser His
Ala Ser His Pro
Ala Ser Pro His
Gly His Pro Thr
Gly His Thr Pro
Gly Pro His Thr
Gly Pro Thr His
Gly Thr His Pro
Gly Thr Pro His
His Ala Pro Ser
His Ala Ser Pro
His Gly Pro Thr
His Gly Thr Pro
His Pro Ala Ser
His Pro Gly Thr
His Pro Ser Ala
His Pro Thr Gly
His Ser Ala Pro
His Ser Pro Ala
His Thr Gly Pro
His Thr Pro Gly
Pro Ala His Ser
Pro Ala Ser His
Pro Gly His Thr
Pro Gly Thr His
Pro His Ala Ser
Pro His Gly Thr
Pro His Ser Ala
Pro His Thr Gly
Pro Ser Ala His
Pro Ser His Ala
Pro Thr Gly His
Pro Thr His Gly
Quinaprilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Ser Ala His Pro
Ser Ala Pro His
Ser His Ala Pro
Ser His Pro Ala
Ser Pro Ala His
Ser Pro His Ala
Thr Gly His Pro
Thr Gly Pro His
Thr His Gly Pro
Thr His Pro Gly
Thr Pro Gly His
Thr Pro His Gly
Tafluprost acid
Kanzonol Y
Diflorasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
heliocide H3
Pteroside A
Heliocide H1
heliocide H4
Pteroside D
heliocide H2
Scorzoside
2-[2-(2,3-dihydro-5-methoxy-2,3,3-trimethyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium chloride
2,7-DI-TERT-BUTYL-9,9-DIMETHYL-4,5-XANTHENEDICARBOXYLIC ACID
4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline
1-BOC-3-[1-(4-FLUORO-BENZYL)-1H-BENZOIMIDAZOL-2-YLAMINO]-PYRROLIDINE
3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one (Risperidone IMpurity)
4,4-((Propane-2,2-diylbis(4,1-phenylene))bis(oxy))dianiline
Famitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N1-(1-Dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-N4-(2-pyridin-2-YL-ethyl)-succinamide
Navarixin anhydrous
C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist
(Z)-7-((1R,2R,3R,5S)-2-((E)-3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid
2,5-Bis(3,5-dimethyl-1-phenyl-4-pyrazolyl)-1,3,4-oxadiazole
methyl (1R,9S,11S,14E,15S,17S,19R)-19-(acetyloxymethyl)-14-ethylidene-18-oxa-2,12-diazahexacyclo[9.6.1.19,15.01,9.03,8.012,17]nonadeca-3,5,7-triene-19-carboxylate
N-[(E)-{2-[cyclohexyl(methyl)amino]-5-nitrophenyl}methylidene]-2-phenoxyacetohydrazide
Isobrucine N-oxide
A monoterpenoid indole alkaloid with formula C23H26N2O5, originally isolated from the seeds of Strychnos nux-vomica.
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]oxan-3-yl]-3-piperidin-1-ylpropanamide
(1R,5S)-3-(1,3-benzodioxol-5-ylmethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane
2-cyclopropyl-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide
2-cyclopropyl-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
N-[2-[(2S,5S,6R)-5-(benzylsulfonylamino)-6-(hydroxymethyl)oxan-2-yl]ethyl]cyclobutanecarboxamide
2-cyclopropyl-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
2-cyclopropyl-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide
2-cyclopropyl-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]oxan-3-yl]acetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]oxan-3-yl]-3-piperidin-1-ylpropanamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]oxan-3-yl]-3-piperidin-1-ylpropanamide
N-[2-[(2R,5S,6R)-5-(benzylsulfonylamino)-6-(hydroxymethyl)oxan-2-yl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
2-cyclopropyl-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
2-cyclopropyl-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
[(3aR,4R,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
1-[(2S,3S)-3-[4-(4-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(1-oxopropyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
2-cyclopropyl-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[(4-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]acetamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(phenylmethyl)sulfonylamino]-2-oxanyl]ethyl]cyclobutanecarboxamide
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(2-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
[(3aR,4S,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aS,4R,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aS,4S,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
1-[(2R,3R)-3-[4-(4-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(1-oxopropyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
1-[(2R,3S)-3-[4-(4-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(1-oxopropyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
1-[(2S,3R)-3-[4-(4-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(1-oxopropyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
1-[2-(Dimethylamino)ethyl]-4-(5-methylfuran-2-carbonyl)-5-(3-prop-2-enoxyphenyl)pyrrolidine-2,3-dione
19-O-acetylhoerhammericine
An Aspidosperma alkaloid that is hoerhammericine in which the hydroxy group at position 19 has been converted to the corresponding acetate ester. Note the stereoconfiguration of the epoxy group is based on CHEBI:144374, and that of the 19-acetoxy group on the hydroxy group of CHEBI:144372.
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) nonanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) octanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) decanoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) tridecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) dodecanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) undecanoate
6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h-inden-1-one
3-(3,4-dihydroxyphenyl)-1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxyphenyl]propan-1-one
(3as,9s,11as)-6,10-dimethyl-3-methylidene-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(1r,13r,14s,15r,18s,19s)-9,14,18-trimethyl-13-(3-methylbutanoyl)-4,12,20-trioxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁵,¹⁹]icosa-2(11),5,7,9-tetraen-3-one
(1r,4as,8r,8as)-7,8-diformyl-4,4,8a-trimethyl-1,2,3,4a,5,8-hexahydronaphthalen-1-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate
methyl 5-hydroxy-10-(hydroxymethyl)-4-[(3-methylbutanoyl)oxy]-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,10h,11h,11ah-cyclodeca[b]furan-6-carboxylate
(2r,4r)-4-ethenyl-2-hydroxy-4,10-dimethyl-2-[(2r,3r)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]-3h-pyrano[3,2-c]chromen-5-one
(3as,11ar)-6-methyl-3-methylidene-10-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
2'-hydroxy-5,8a,11'-trimethyl-5,6,7,8,9,9a-hexahydro-3ah-6',8'-dioxaspiro[naphtho[2,3-b]furan-3,5'-tricyclo[7.4.0.0²,⁷]tridecane]-1'(13'),9',11'-trien-2-one
methyl (1r,4s,12r,13r,21s)-7,8-dimethoxy-20-oxo-5,15-diazahexacyclo[11.5.2.1¹,¹².0⁴,¹².0⁶,¹¹.0¹⁵,²¹]henicosa-6,8,10,17-tetraene-4-carboxylate
methyl (14e)-19-[(acetyloxy)methyl]-14-ethylidene-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
(1s,6r,8r,11r,12r,13s,23r)-18-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15,17,19-triene-21,24-dione
(1s,2s,3r,4r,5s)-5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
methyl (2z)-7-(6,7-dimethoxyquinolin-4-yl)-2-ethylidene-6-oxa-4-azatricyclo[5.2.1.0⁴,⁸]decane-10-carboxylate
(5r,6s,7as)-6-ethenyl-3,6-dimethyl-5-(3-{[(2r,4s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-4,5,7,7a-tetrahydro-1-benzofuran-2-one
4-ethenyl-2-hydroxy-4,10-dimethyl-2-[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]-3h-pyrano[3,2-c]chromen-5-one
3-[(1s,4as,7s,7ar)-4,7-dimethyl-3-(3-methylbutanoyl)-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]-4-hydroxy-5-methylchromen-2-one
methyl 2-{13-formyl-8,16-dimethyl-12-oxo-11-oxa-8,16-diazapentacyclo[7.4.3.2¹⁰,¹³.0¹,⁹.0²,⁷]octadeca-2,4,6-trien-17-yl}but-2-enoate
(8s,8ar,10as)-2,3-dihydroxy-4-isopropyl-7,10a-dimethyl-8-(3-methylbut-2-en-1-yl)-9,10-dioxo-8,8a-dihydro-5h-anthracene-1-carbaldehyde
7,8-diformyl-4,4,8a-trimethyl-1,2,3,4a,5,8-hexahydronaphthalen-1-yl 3-(4-methoxyphenyl)prop-2-enoate
(3ar,4as,7s,8ar,9ar)-8a-methyl-3,5-dimethylidene-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydronaphtho[2,3-b]furan-2-one
2,19-dimethyl (1s,9r,16s,19r,20r)-21-oxo-2,12-diazahexacyclo[10.6.2.1⁹,¹⁶.0¹,⁹.0³,⁸.0¹⁶,²⁰]henicosa-3,5,7-triene-2,19-dicarboxylate
2,18-dimethyl (1r,9s,16s)-21-oxo-2,12-diazapentacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸]henicosa-3,5,7,17-tetraene-2,18-dicarboxylate
methyl (2e)-2-[(1s,9s,10r,13s,17s)-13-formyl-8,16-dimethyl-12-oxo-11-oxa-8,16-diazapentacyclo[7.4.3.2¹⁰,¹³.0¹,⁹.0²,⁷]octadeca-2,4,6-trien-17-yl]but-2-enoate
(2e,4e,6e)-7-[(2s,4's,4'ar,5'r,7's)-5,5',7'-trimethyl-3,6'-dioxo-3',4',4'a,5',7',8'-hexahydrospiro[furan-2,2'-naphthalen]-4'-yl]-4,6-dimethylhepta-2,4,6-trienoic acid
methyl (1r,2e,7s,8s,10s)-7-(6,7-dimethoxyquinolin-4-yl)-2-ethylidene-6-oxa-4-azatricyclo[5.2.1.0⁴,⁸]decane-10-carboxylate
(3as,4r,4as,5r,7s,7as,8s,9r,9ar)-4-(acetyloxy)-5,9-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-7-yl 2-methylpropanoate
3,8,8,14-tetramethyl-21-methylidene-7,18-dioxahexacyclo[12.7.1.0²,¹².0³,⁹.0¹²,²⁰.0¹⁶,²⁰]docos-4-ene-6,17,22-trione
(3s,3as,6ar,8s,9ar,9bs)-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one
(8r,8as,10ar)-2,3-dihydroxy-4-isopropyl-7,10a-dimethyl-8-(3-methylbut-2-en-1-yl)-9,10-dioxo-8,8a-dihydro-5h-anthracene-1-carbaldehyde
(1r,2s,3r,9r,12s,14r,16s,20s)-3,8,8,14-tetramethyl-21-methylidene-7,18-dioxahexacyclo[12.7.1.0²,¹².0³,⁹.0¹²,²⁰.0¹⁶,²⁰]docos-4-ene-6,17,22-trione
7-(3,7-dimethylocta-2,6-dien-1-yl)-3,6,8,9-tetrahydroxy-3-methyl-2,4-dihydroanthracen-1-one
13-(3-hydroxy-3-methylbut-1-en-1-yl)-9,14,18-trimethyl-4,12,20-trioxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁵,¹⁹]icosa-2(11),5,7,9-tetraen-3-one
3-methyl-6,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one
8a,9a-dihydroxy-4-methoxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-6-yl 4-hydroxypent-3-enoate
(3s)-3-hydroxy-2,2,5,7-tetramethyl-6-(2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-3h-inden-1-one
11ɑ,13-dihydrozaluzanin-C
{"Ingredient_id": "HBIN000278","Ingredient_name": "11\u0251,13-dihydrozaluzanin-C","Alias": "NA","Ingredient_formula": "C21H30O8","Ingredient_Smile": "CC1C2CCC(=C)C3CC(C(=C)C3C2OC1=O)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42851","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,3-dihydro-7-methoxy-2s*,3r*-dimethyl-2-[4,8-dimethyl-3(e),7-nonadien-6-onyl]-furo[3,2-c]coumarin
{"Ingredient_id": "HBIN004013","Ingredient_name": "2,3-dihydro-7-methoxy-2s*,3r*-dimethyl-2-[4,8-dimethyl-3(e),7-nonadien-6-onyl]-furo[3,2-c]coumarin","Alias": "NA","Ingredient_formula": "C25H30O5","Ingredient_Smile": "CC1C2=C(C3=C(C=C(C=C3)OC)OC2=O)OC1(C)CCC=C(C)CC(=O)C=C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5665","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β,6β,8α-triacetoxy-4β,5α-epoxy-1-oxo-germacr-10(14)-ene
{"Ingredient_id": "HBIN008101","Ingredient_name": "3\u03b2,6\u03b2,8\u03b1-triacetoxy-4\u03b2,5\u03b1-epoxy-1-oxo-germacr-10(14)-ene","Alias": "NA","Ingredient_formula": "C21H30O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21503","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}